drugset

drugset / Trial / NCT00683189

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

NCT00683189 ↗

Completed 10 enrolled The Cooper Health System

NaSingle-groupOpen-labelTreatment

Summary

Objectives/Purpose: To determine the safety and efficacy of a Vitamin K (Vit K) antagonist (warfarin) in treating Metachromatic Leukodystrophy (MLD).

Timeline

Start: 2007-06
Primary completion: 2008-05
Completion: 2008-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Warfarin	Small molecule	1.5 mg	Oral

Indications